Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

Market Cap	24.90B
Revenue (ttm)	8.92B
Net Income (ttm)	2.78B
Shares Out	921.70M
EPS (ttm)	3.03
PE Ratio	8.93
Forward PE	8.66
Dividend	1.30 (4.81%)
Ex-Dividend Date	Jun 17, 2024

Volume	4,994,431
Average Volume	5,410,297
Open	27.11
Previous Close	27.12
Day's Range	26.92 - 27.32
52-Week Range	23.85 - 45.18
Beta	0.20
RSI	41.64
Earnings Date	Apr 26, 2025

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, neurology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develop...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Fei Cao
• Employees: 5,230
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600566

Financial Performance

In 2023, SHA:600566's revenue was 9.65 billion, an increase of 7.32% compared to the previous year's 9.00 billion. Earnings were 2.82 billion, an increase of 30.04%.